Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomedicine as potential cancer therapy via targeting dysregulated transcription factors
Anas Ahmad, Summya Rashid, Anis Ahmad Chaudhary, et al.
Seminars in Cancer Biology (2023) Vol. 89, pp. 38-60
Closed Access | Times Cited: 21

Showing 21 citing articles:

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 87
Polymer Nanoparticles for Cancer Immunotherapy: Preparation Methods and Applications
Ashish Kumar Parashar, Vandana Arora Sethi
Nature Cell and Science (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 10
Impact of biogenic zinc oxide nanoparticles on physiological and biochemical attributes of pea (Pisum sativum L.) under drought stress
Aneeza Ishfaq, Irfan Haidri, Usman Shafqat, et al.
Physiology and Molecular Biology of Plants (2025) Vol. 31, Iss. 1, pp. 11-26
Closed Access | Times Cited: 1
Targeting Cancer Stemness Using Nanotechnology in a Holistic Approach: A Narrative Review
Melinda-Ildiko Mitranovici, Laura Caravia, Liviu Moraru, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 277-277
Open Access | Times Cited: 1
Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
Xin Zhang, Xuemei Wang, Lijian Hou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism
Pei Lin, Ye Lu, Jiarong Zheng, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Nanomedicine-induced programmed cell death in cancer therapy: mechanisms and perspectives
Luobin Lin, He Wanxin, Yingxin Guo, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Exploration of sialic acid receptors as a potential target for cancer treatment: A comprehensive review
Meheli Ghosh, P Hazarika, S Dhanya, et al.
International Journal of Biological Macromolecules (2023) Vol. 257, pp. 128415-128415
Closed Access | Times Cited: 11
From micro to macro, nanotechnology demystifies acute pancreatitis: a new generation of treatment options emerges
Wei Du, Xinyue Wang, Yuyan Zhou, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Nano-strategies for Targeting Tumor-Associated Macrophages in Cancer immunotherapy
Qian Li, Jingwei Xu, Rong Hua, et al.
Journal of Cancer (2025) Vol. 16, Iss. 7, pp. 2261-2274
Open Access
Decoy oligonucleotides targeting NF-κB: a promising therapeutic approach for inflammatory diseases
Maryam Mahjoubin‐Tehran, Samaneh Rezaei, Alexandra E. Butler, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Closed Access
STAT3 Signaling Pathway in Health and Disease
Md Abdus Samad, Iftikhar Ahmad, A. M. Mahedi Hasan, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Pharmacoscintigraphy: Advancing Nanotheranostic Development Through Radionuclide Imaging
María Jimena Salgueiro, Marcela A. Morettón, Vanina A. Medina, et al.
Journal of Nanotheranostics (2025) Vol. 6, Iss. 2, pp. 12-12
Open Access
Microenvironment of pancreatic inflammation: calling for nanotechnology for diagnosis and treatment
Lu Liu, Yiqing Zhang, Xinghui Li, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Current concepts of the crosstalk between lncRNA and E2F1: shedding light on the cancer therapy
Peng Huang, Feng Wen, Qiu Li
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Circular RNAs and the JAK/STAT pathway: New frontiers in cancer therapeutics
Waleed Hassan Almalki, Salem Salman Almujri
Pathology - Research and Practice (2024) Vol. 260, pp. 155408-155408
Closed Access | Times Cited: 2
Multifaceted roles of crocin, phytoconstituent of Crocus sativus L. in cancer treatment: An expanding horizon
Yachana Mishra, Vijay Mishra
South African Journal of Botany (2023) Vol. 160, pp. 456-468
Closed Access | Times Cited: 5
Bacteria associated with glioma: a next wave in cancer treatment
Yiming Meng, Jing Sun, Guirong Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 2
Biomembrane-derived nanoplexes for SiRNAs-pioneer innovation in delivery to lung adenocarcinoma
Dilpreet Singh
Journal of Nanoparticle Research (2024) Vol. 26, Iss. 3
Closed Access
The SAR analysis of dietary polyphenols and their antagonistic effects on bortezomib at physiological concentrations
Trương Thị Bạch Vân, Hsun‐Shuo Chang, Ho‐Cheng Wu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Special issue: Deregulated transcription factors in the cancer therapeutic challenges: An update on cancer stemness features
Abdul Quaiyoom Khan
Seminars in Cancer Biology (2023) Vol. 96, pp. 3-4
Closed Access | Times Cited: 1
Page 1

Scroll to top